Bayer Accused of ‘Pay to Appeal Scheme’ by Roundup Lawyers
Bayer AG’s strategy to get a favorable ruling in its Roundup litigation is a manufactured “pay-to-appeal scheme” that will erode the U.S.
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.